IDH2 and chondrosarcoma: Eighty-seven percent of the solitary and multiple enchondromas, ~ 50% of the primary central conventional chondrosarcomas and 86% of the secondary central chondrosarcomas harbour heterozygous point mutations in IDH1 and IDH2 [6, 25, 26].